Recently, the Wall Street Journal quoted people familiar with the matter as saying that Valeant is seeking to sell the Bausch & Lomb eye surgery business acquired three years ago, with a valuation of $2.5 billion. It is still in its early stages, so it is not clear what the potential acquirers are, and Valeant may still decide not to sell the business. Bausch & Lomb is a well-known manufacturer of eye care products in the United States. It manufactures and sells eye protection products, contact lenses, contact lens care products and eye surgery equipment. It is one of the world's leading manufacturers. According to people familiar with the matter, Valeant hopes to retain Bausch & Lomb's business in addition to eye surgery equipment. Valeant Pharmaceuticals International is a comprehensive pharmaceutical company that develops, manufactures and markets branded drugs across the globe. Headquartered in Canada. The hedge fund, Bill Ackman's fund company, Pershing Square Capital Management, is the controlling party of Valeant. The company obtained huge profits by acquiring the developed pharmaceutical company and cutting off most of the employees of the purchased company. IV Solutions for Liver Disease Iv Solutions For Liver Disease,Marine And Sodium Chloride Injection,Matrine And Glucose Injection,Marine Injection Shandong Qidu Pharmaceutical Co., Ltd. , https://www.qdyypharma.com